197 related articles for article (PubMed ID: 25481284)
1. Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine.
Papaneri AB; Bernbaum JG; Blaney JE; Jahrling PB; Schnell MJ; Johnson RF
Virus Res; 2015 Feb; 197():54-8. PubMed ID: 25481284
[TBL] [Abstract][Full Text] [Related]
2. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
Blaney JE; Wirblich C; Papaneri AB; Johnson RF; Myers CJ; Juelich TL; Holbrook MR; Freiberg AN; Bernbaum JG; Jahrling PB; Paragas J; Schnell MJ
J Virol; 2011 Oct; 85(20):10605-16. PubMed ID: 21849459
[TBL] [Abstract][Full Text] [Related]
3. Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.
Blaney JE; Marzi A; Willet M; Papaneri AB; Wirblich C; Feldmann F; Holbrook M; Jahrling P; Feldmann H; Schnell MJ
PLoS Pathog; 2013; 9(5):e1003389. PubMed ID: 23737747
[TBL] [Abstract][Full Text] [Related]
4. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
J Virol; 2017 May; 91(10):. PubMed ID: 28250127
[TBL] [Abstract][Full Text] [Related]
6. A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.
Papaneri AB; Wirblich C; Cann JA; Cooper K; Jahrling PB; Schnell MJ; Blaney JE
Virology; 2012 Dec; 434(1):18-26. PubMed ID: 22889613
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
[TBL] [Abstract][Full Text] [Related]
8. Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.
Kurup D; Fisher CR; Smith TG; Abreu-Mota T; Yang Y; Jackson FR; Gallardo-Romero N; Franka R; Bronshtein V; Schnell MJ
J Infect Dis; 2019 Sep; 220(9):1521-1528. PubMed ID: 31374568
[TBL] [Abstract][Full Text] [Related]
9. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
10. Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.
Papaneri AB; Wirblich C; Cooper K; Jahrling PB; Schnell MJ; Blaney JE
Vaccine; 2012 Sep; 30(43):6136-41. PubMed ID: 22884661
[TBL] [Abstract][Full Text] [Related]
11. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
[TBL] [Abstract][Full Text] [Related]
12. An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.
Johnson RF; Kurup D; Hagen KR; Fisher C; Keshwara R; Papaneri A; Perry DL; Cooper K; Jahrling PB; Wang JT; Ter Meulen J; Wirblich C; Schnell MJ
J Infect Dis; 2016 Oct; 214(suppl 3):S342-S354. PubMed ID: 27456709
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
15. Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus.
Wong G; Qiu X
Methods Mol Biol; 2016; 1403():245-57. PubMed ID: 27076134
[TBL] [Abstract][Full Text] [Related]
16. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
18. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
19. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]